Takeda gets enough takers to complete $2.3B Actos settlement

Eric Palmer

A month ago it appeared like might not get to move forward with its sweeping $ 2.3 billion offer to settle thousands of claims over the cancer risks of diabetes drug . But over the weekend, the Japanese drugmaker said it had raised the offer by $ 100 million if certain conditions are hit and now has enough on board to trigger the $ 2.3 billion .

FiercePharma News

Share This Post

Related Articles

Leave a Reply

© 2019 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS